Systemic administration of attenuated Salmonella choleraesuis in combination with cisplatin for cancer therapy
Open Access
- 1 May 2005
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 11 (5) , 707-716
- https://doi.org/10.1016/j.ymthe.2005.01.008
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Endostatin gene therapy delivered by Salmonella choleraesuis in murine tumor modelsThe Journal of Gene Medicine, 2004
- Systemic administration of attenuated Salmonella choleraesuis carrying thrombospondin-1 gene leads to tumor-specific transgene expression, delayed tumor growth and prolonged survival in the murine melanoma modelCancer Gene Therapy, 2004
- Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteinsNature Biotechnology, 2004
- Bacteria as tumour-targeting vectorsThe Lancet Oncology, 2003
- Bifidobacterium adolescentis as a delivery system of endostatin for cancer gene therapy: Selective inhibitor of angiogenesis and hypoxic tumor growthCancer Gene Therapy, 2003
- Tumor-Targeted Salmonella Expressing Cytosine Deaminase as an Anticancer AgentHuman Gene Therapy, 2002
- Prothymosin α enhances protective immune responses induced by oral DNA vaccination against pseudorabies delivered by Salmonella choleraesuisVaccine, 2001
- MURINE IL-2 SECRETING RECOMBINANT BACILLUS CALMETTE-GUÉRIN AUGMENTS MACROPHAGE-MEDIATED CYTOTOXICITY AGAINST MURINE BLADDER CANCER MBT-2Journal of Urology, 2000
- Lipid A mutant Salmonella with suppressed virulence and TNFα induction retain tumor-targeting in vivoNature Biotechnology, 1999
- Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumoursNature, 1996